Structure Therapeutics Inc.

GPCR | NASDAQ

Price Alert Chart Builder DCF Calculator

$36.79

-$0.02 (-0.05%)

Sep 22, 2026, 10:46 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-141.2M	-122.53M	-89.62M	-51.32M	-38.05M	-15.88M
Depreciation & Amortization	1.33M	992K	295K	277K	72K	n/a
Stock-Based Compensation	28.99M	18.79M	8.19M	2.51M	1.49M	570K
Other Working Capital	-93.05M	-343K	7.83M	815K	2.17M	-74K
Other Non-Cash Items	-23.05M	-16.86M	-5.32M	-558K	268K	77K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-88.27M	2.96M	6.97M	2.97M	4.06M	946K
Operating Cash Flow	-222.2M	-116.64M	-79.49M	-46.12M	-32.16M	-14.28M
Capital Expenditures	-3.61M	-1.29M	-2.17M	-155K	-1.21M	-19K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-547.38M	-702.52M	-416.99M	-123.45M	-4.21M	-21.13M
Sales Maturities Of Investments	630.54M	344.9M	151.05M	61.5M	23.28M	n/a
Other Investing Acitivies	10.25M	n/a	-231.38K	n/a	n/a	n/a
Investing Cash Flow	89.8M	-358.91M	-268.34M	-62.11M	17.86M	-21.15M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4.66M	690K	-20.77M	-2.49M	-104K	n/a
Financial Cash Flow	762.52M	515.26M	451.53M	29.01M	103.25M	25.84M
Net Cash Flow	630.12M	39.72M	103.7M	-79.21M	88.95M	-9.59M
Free Cash Flow	-225.81M	-117.93M	-81.66M	-46.28M	-33.37M	-14.3M
Adj. Free Cash Flow	-254.8M	-136.72M	-89.85M	-48.79M	-34.85M	-14.87M
Maintenance CapEx	-1.33M	-992K	-295K	-155K	-72K	n/a
Growth CapEx	-2.28M	-298K	-1.87M	n/a	-1.13M	-19K
Owner Earnings	-223.53M	-117.63M	-79.78M	-46.28M	-32.23M	-14.28M